Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Recurrence × Other × Clear all

Status

Sponsor Class

OTHER 3 NETWORK 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 280 Other hematologic neoplasm 191 Plasma cell 171 Gynecologic 62 Thoracic 47 Head & Neck 46 CNS 40 Gastrointestinal 35 Genitourinary 33 Sarcoma 31 Breast 31 Myeloid 28 Dermatologic 25 Other solid neoplasm 6 Endocrine 3 Classical hematology 2 Other 1

Conditions

Mucositis 22 Opioid-Induced Constipation 19 Constipation 17 Head and Neck Neoplasms 12 Stomatitis 11 Pain 11 Obesity 5 Neoplasms 5 Intestinal Diseases 5 Bronchiolitis Obliterans Syndrome 4 Oral Ulcer 3 Hematologic Neoplasms 3 Chemotherapy-induced Peripheral Neuropathy 3 Breast Neoplasms 3 Xerostomia 2 Venous Thromboembolism 2 Tumor Lysis Syndrome 2 Thrombocytopenia 2 Teratogenesis 2 Sexual Dysfunctions, Psychological 2 Sexual Dysfunction, Physiological 2 Renal Insufficiency 2 Prostatic Neoplasms 2 Peripheral Nervous System Diseases 2 Overweight 2 Neutropenia 2 Myocardial Infarction 2 Multiple Myeloma 2 Mouth Neoplasms 2 Lymphoma 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01020604 2013-04-30

PROTECT-Z

AstraZeneca

GenitourinaryOther

Obesity, Prostatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡